MiR-145: a potential biomarker of cancer migration and invasion

被引:16
|
作者
Xu, Wen-Xiu [1 ,2 ]
Liu, Zhen [1 ,2 ]
Deng, Fei [1 ,2 ]
Wang, Dan-Dan [1 ]
Li, Xing-Wang [3 ]
Tian, Tian [3 ]
Zhang, Jian [1 ]
Tang, Jin-Hai [1 ,2 ]
机构
[1] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing 210029, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Clin Sch 1, Nanjing 210029, Jiangsu, Peoples R China
[3] Xuzhou Med Univ, Sch Clin Med, 209 Tongshan Rd, Xuzhou 221004, Jiangsu, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
MiR-145; cancers; biomarker; invasion and migration; LONG NONCODING RNA; ENDOTHELIAL GROWTH-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; INHIBITS TUMOR-GROWTH; SUPPRESSES CELL INVASION; COLORECTAL-CANCER; MICRORNA-145; TARGETS; PROSTATE-CANCER; GASTRIC-CANCER; DNA HYPERMETHYLATION;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MircoRNAs (miRNAs) are a diverse family of highly conserved small non-coding RNAs, which range from approximately 18 to 25 nucleotides in size. They regulate gene expression transcriptionally or post-transcriptionally via binding to the 3'-untranslated region (3'-UTR) of target message RNAs (mRNAs). MiRNAs have emerged as molecular regulators that participate in physiological and pathological processes of diverse malignancies. Among them, miRNA-145 (miR-145) played a profound role in tumorigenesis and progression of various neoplasms. In this review, we summarized the recent findings regarding miR-145, to elucidate its functional roles in cell invasion and migration of diverse human malignancies, and considered it a potential biomarker for cancer diagnosis, screening, and prognosis.
引用
收藏
页码:6739 / 6753
页数:15
相关论文
共 50 条
  • [21] MiR-145 inhibits cell migration and increases paclitaxel chemosensitivity in prostate cancer cells
    Tohidast, Maryam
    Memari, Neda
    Amini, Mohammad
    Hosseini, Seyed Samad
    Jebelli, Asiyeh
    Doustvandi, Mohammad Amin
    Baradaran, Behzad
    Mokhtarzadeh, Ahad
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2023, 26 (11) : 1350 - 1359
  • [22] Emerging roles of circRNA_001569 targeting miR-145 in the proliferation and invasion of colorectal cancer
    Xie, Huijun
    Ren, Xiaoli
    Xin, Sainan
    Lan, Xiaoliang
    Lu, Guifeng
    Lin, Y.
    Yang, S. S.
    Zeng, Z. C.
    Liao, W. T.
    Ding, Yan-Qing
    Liang, Li
    ONCOTARGET, 2016, 7 (18) : 26680 - 26691
  • [23] miR-145 inhibits invasion and metastasis by directly targeting Smad3 in nasopharyngeal cancer
    Huang, Haiping
    Sun, Peng
    Lei, Zhe
    Li, Manyi
    Wang, Yihong
    Zhang, Hong-Tao
    Liu, Jisheng
    TUMOR BIOLOGY, 2015, 36 (06) : 4123 - 4131
  • [24] Down-regulation of fecal miR-143 and miR-145 as potential markers for colorectal cancer
    Li, Jin-Ming
    Zhao, Rong-Hua
    Li, Shao-Tang
    Xie, Cai-Xia
    Jiang, Hong-Hua
    Ding, Wen-Jun
    Du, Peng
    Chen, Wei
    Yang, Ming
    Cui, Long
    SAUDI MEDICAL JOURNAL, 2012, 33 (01) : 24 - 29
  • [25] MiR-145 functions as a potential tumor suppressor in hepatocellular carcinoma
    Law, Priscilla T. Y.
    Ching, Arthur Kk
    Wong, Queenie W. L.
    Lai, Paul B. S.
    Wong, Nathalie
    CANCER RESEARCH, 2010, 70
  • [26] MIR-126*AND MIR-145 AS POTENTIAL BIOMARKERS FOR NON-SMALL CELL LUNG CANCER
    Fong, Alvin Hong-Wai
    Lai, Jessica Ka-Men
    Li, Jacky Yu-Chung
    Cho, William Chi-Shing
    RESPIROLOGY, 2018, 23 : 85 - 85
  • [27] miR-145 and incident thromboembolism
    Zoller, Bengt
    BLOOD, 2024, 143 (17) : 1686 - 1687
  • [28] Demethylation of the MIR145 promoter suppresses migration and invasion in breast cancer
    Liu, Shui-Yi
    Li, Xiao-Yi
    Chen, Wei-Qun
    Hu, Hui
    Luo, Bo
    Shi, Yu-Xiang
    Wu, Tang-Wei
    Li, Yong
    Kong, Qing-Zhi
    Lu, Hong-Da
    Lu, Zhong-Xin
    ONCOTARGET, 2017, 8 (37) : 61731 - 61741
  • [29] The role of miR-145 in microvasculature
    Ji, Li-ya
    Jiang, De-qian
    Dong, Ni-ni
    PHARMAZIE, 2013, 68 (06): : 387 - 391
  • [30] Epigenetically regulated miR-145 suppresses colon cancer invasion and metastasis by targeting LASP1
    Wang, Wei
    Ji, Gang
    Xiao, Xin
    Chen, Xu
    Qin, Wei-Wei
    Yang, Fan
    Li, Yu-Fang
    Fan, Lin-Ni
    Xi, Wen-Jin
    Huo, Yi
    Wen, Wei-Hong
    Yang, An-Gang
    Wang, Tao
    ONCOTARGET, 2016, 7 (42) : 68674 - 68687